$5.86 Billion is the total value of IRIDIAN ASSET MANAGEMENT LLC/CT's 119 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | ANTHEM INCcall | $3,410,000 | +11.8% | 9,500 | 0.0% | 0.06% | +3.6% | |
| BRKB | BERKSHIRE HATHAWAY INC | $2,603,000 | +10.2% | 10,189 | 0.0% | 0.04% | +2.3% | |
| BAM | BROOKFIELD ASSET MANAGEMENT INC | $1,872,000 | +7.8% | 42,060 | 0.0% | 0.03% | 0.0% | |
| INVA | INNOVIVA INC | $1,494,000 | -3.6% | 125,003 | 0.0% | 0.02% | -10.7% | |
| KEYS | KEYSIGHT TECHNOLOGIES INC | $1,377,000 | +8.6% | 9,600 | 0.0% | 0.02% | 0.0% | |
| CNDT | CONDUENT INC | $1,038,000 | +38.8% | 155,846 | 0.0% | 0.02% | +28.6% | |
| LH | LABORATORY CORP OF AMERICA HOLDINGScall | $893,000 | +25.4% | 3,500 | 0.0% | 0.02% | +15.4% | |
| MAR | MARRIOTT INTERNATIONAL INC/MD | $863,000 | +12.2% | 5,828 | 0.0% | 0.02% | +7.1% | |
| IIVI | II-VI INC | $697,000 | -10.1% | 10,200 | 0.0% | 0.01% | -14.3% | |
| BBIO | BRIDGEBIO PHARMA INCcall | $474,000 | -13.5% | 7,700 | 0.0% | 0.01% | -20.0% | |
| TXT | TEXTRON INC | $406,000 | +16.0% | 7,239 | 0.0% | 0.01% | +16.7% | |
| UBER | UBER TECHNOLOGIES INCcall | $153,000 | +7.0% | 2,800 | 0.0% | 0.00% | 0.0% | |
| TXMD | THERAPEUTICSMD INC | $112,000 | +10.9% | 83,305 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WYNDHAM WORLDWIDE CORP | 31 | Q4 2020 | 4.8% |
| WR GRACE & CO | 30 | Q3 2020 | 5.0% |
| VISTEON CORP | 30 | Q3 2021 | 2.9% |
| POST HOLDINGS INC. | 29 | Q3 2023 | 5.4% |
| LABORATORY CORP OF AMERICA HOLDINGS | 29 | Q3 2023 | 4.7% |
| UNIVAR USA INC | 29 | Q2 2023 | 4.6% |
| HALOZYME THERAPEUTICS INC | 29 | Q3 2020 | 1.8% |
| FLEXTRONICS INTL LTD | 27 | Q3 2023 | 5.1% |
| BALL CORPORATION | 27 | Q4 2022 | 3.3% |
| INTERCONTINENTAL EXCHANGE INC | 25 | Q3 2023 | 3.6% |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Axsome Therapeutics, Inc. | January 18, 2022 | ? | ? |
| Katapult Holdings, Inc. | January 18, 2022 | ? | ? |
| Travel & Leisure Co. | January 18, 2022 | ? | ? |
| Chemours Co | January 28, 2020 | ? | ? |
| HALOZYME THERAPEUTICS, INC. | January 28, 2020 | ? | ? |
| MEDICINES CO /DE | January 28, 2020 | ? | ? |
| Univar Solutions Inc. | January 28, 2020 | ? | ? |
| VISTEON CORP | November 04, 2019 | ? | ? |
| ALLEGHENY TECHNOLOGIES INC | February 06, 2019 | ? | ? |
| ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. | February 06, 2019 | ? | ? |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-01 |
| 13F-HR | 2024-01-26 |
| SC 13G/A | 2024-01-24 |
| 13F-HR | 2023-10-30 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-04-28 |
| SC 13G | 2023-02-03 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-29 |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.